Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2 Biotech Companies Investors Should Watch As Analysts Initiate Buy Ratings
Seeking Alpha
Sunday, October 14, 2012 - 11:13am
tags:
AcelRx, Meridian Bioscience
Watson's Generic Sanctura XR Receives FDA Approval
Melodika
Sunday, October 14, 2012 - 11:11am
tags:
Watson Pharmaceuticals, Sanctura XR, generics
Why Is Eli Lilly Climbing?
Motley Fool
Sunday, October 14, 2012 - 11:09am
tags:
Eli Lilly
India Patent Authority Has Big Pharma Worried
Connecticut Law Tribune, CT
Sunday, October 14, 2012 - 11:08am
tags:
patents
NPS Pharmaceuticals: Buy If There Is A Dip
Seeking Alpha
Sunday, October 14, 2012 - 11:06am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sunday, October 14, 2012 - 11:04am
tags:
Eli Lilly, Valeant Pharmaceuticals, Lexicon Pharmaceuticals, Sarepta Therapeutics, Amarin, NPS Pharmaceuticals, Aeterna Zentaris
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sunday, October 14, 2012 - 11:02am
tags:
Celgene, NPS Pharmaceuticals, lung cancer, Abraxane, Gattex, short bowel syndrome
Questcor Pharmaceuticals: Turning Bullish As Volatility Continues
Seeking Alpha
Sunday, October 14, 2012 - 10:59am
tags:
Questcor Pharmaceuticals
Our Fourth Nominee for Worst CEO of the Year: Lamberto Andreotti
Motley Fool
Sunday, October 14, 2012 - 10:57am
tags:
Bristol-Myers Squibb, Lamberto Andreotti
United States : White & Case Secures Victory in AndroGel Antitrust Class Actions
equities.com
Saturday, October 13, 2012 - 12:46pm
tags:
patents, Par Pharmaceutical, Paddock Laboratories, lawsuits, generics, Androgel
Valeant Pharmaceuticals Outpaces Peer Sales Growth
investors.com
Saturday, October 13, 2012 - 12:43pm
tags:
Valeant Pharmaceuticals
Abbott Labs Eyes Russian Pharmaceutical Market
Trefis
Saturday, October 13, 2012 - 12:42pm
tags:
Abbott Laboratories
Paladin Labs signs agreement with QRxPharma for acute pain product
equities.com
Saturday, October 13, 2012 - 12:41pm
tags:
MoxDuo, pain management, Paladin, QRxPharma
Arena's Bullish Pattern
ForexPros
Saturday, October 13, 2012 - 12:39pm
tags:
Arena Pharmaceuticals
Merck osteoporosis drug builds bone density in mid-stage trial
Reuters
Saturday, October 13, 2012 - 12:31pm
tags:
Merck, osteoporosis, Odanacatib
Should I Buy AstraZeneca?
Motley Fool
Saturday, October 13, 2012 - 12:30pm
tags:
AstraZeneca
Pharmas Across The Pond
Motley Fool
Saturday, October 13, 2012 - 12:30pm
tags:
AstraZeneca, GSK, Sanofi
Johnson & Johnson Third Quarter Earnings Sneak Peek
Wall St Cheat Street
Saturday, October 13, 2012 - 12:28pm
tags:
JNJ, earnings
Here’s Another Misstep for Pfizer to Explain
Wall St Cheat Street
Saturday, October 13, 2012 - 12:27pm
tags:
Pfizer
Does This FDA Approval Mean Anything?
Motley Fool
Saturday, October 13, 2012 - 12:26pm
tags:
Perrigo, smoking cessation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.